Amgen Announces Collaboration With Two NHS Organisations to Help Improve Cholesterol Management for People at High Risk of a Heart Attack or Stroke

CAMBRIDGE, England--(BUSINESS WIRE)--Amgen today announced a new partnership with two NHS organisations, the North West Coast Innovation Agency and Imperial College Health Partners. This collaboration will help tackle the ‘silent killer’ of high cholesterol across the North West Coast of England – an area heavily impacted by heart attacks, strokes, and premature deaths due to cardiovascular disease (CVD). ‘Control Cholesterol: Collaborating to Reduce Risk’ is an innovative two-year programme ad

Click to view original post